会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Process for preparing pharmacologically acceptable salt of N-(1(S)-ethoxycarbonyl-3-phenylpropyl)-L-alanyl amino acids
    • 制备N-(1(S) - 乙氧基羰基-3-苯基丙基)-L-丙氨酰氨基酸的药理学可接受盐的方法
    • US06335453B1
    • 2002-01-01
    • US09269107
    • 1999-03-19
    • Yasuyoshi UedaKoichi KinoshitaTadashi MoroshimaYoshifumi YanagidaYoshihide Fuse
    • Yasuyoshi UedaKoichi KinoshitaTadashi MoroshimaYoshifumi YanagidaYoshihide Fuse
    • C07K5062
    • C07K5/0222C07K5/06026
    • There is provided a process for preparing a pharmacologically acceptable salt of N-(1(S)-ethoxycarbonyl-3-phenylpropyl)-L-alanyl-amino acid which comprises condensing an amino acid and N-(1(S)-ethoxycarbonyl-3-phenylpropyl)-L-alanine.N-carboxyanhydride under basic condition, carrying out decarboxylation under between neutral and acidic condition to obtain N-(1(S)-ethoxycarbonyl-3-phenylpropyl)-L-alanyl-amino acid, and forming a pharmacologically acceptable salt thereof, wherein the production of a by-product (3): is suppressed by carrying out in an aqueous liquid a series of operations till formation of the pharmacologically acceptable salt or till isolation of the pharmacologically acceptable salt. The present invention enables to prepare the pharmacologically acceptable salt of N-(1(S)-ethoxycarbonyl-3-phenylpropyl)-L-alanyl-amino acid having high quality, in a commercial scale with high yield and economical efficiency.
    • 提供了制备N-(1(S) - 乙氧基羰基-3-苯基丙基)-L-丙氨酰 - 氨基酸的药学上可接受的盐的方法,其包括将氨基酸和N-(1(S) - 乙氧基羰基 - 3-苯基丙基)-L-丙氨酸N-羧酸酐,在中性和酸性条件下进行脱羧,得到N-(1(S) - 乙氧基羰基-3-苯基丙基)-L-丙氨酰 - 氨基酸,和 形成其药理学上可接受的盐,其中通过在含水液体中进行一系列操作直到形成药理学上可接受的盐或直到药理学上可接受的盐的分离来抑制副产物(3)的产生。 本发明能够以高产率和经济效益以商业规模制备质量高的N-(1(S) - 乙氧基羰基-3-苯基丙基)-L-丙氨酰 - 氨基酸的药理学上可接受的盐。
    • 2. 发明授权
    • Process for preparing pharmacologically acceptable salt of n-(1(s)-ethoxycarbonyl-3-phenylpropyl)-L-alanyl-amino acid
    • 制备正((S) - 乙氧基羰基-3-苯基丙基)-L-丙氨酰 - 氨基酸的药学上可接受的盐的方法
    • US06518436B2
    • 2003-02-11
    • US09989186
    • 2001-11-21
    • Yasuyoshi UedaKoichi KinoshitaTadashi MoroshimaYoshifumi YanagidaYoshihide Fuse
    • Yasuyoshi UedaKoichi KinoshitaTadashi MoroshimaYoshifumi YanagidaYoshihide Fuse
    • C07D20704
    • C07K5/0222C07K5/06026
    • There is provided a process for preparing a pharmacologically acceptable salt of N-(1(S)-ethoxycarbonyl-3-phenylpropyl)-L-alanyl-amino acid which comprises condensing an amino acid and N-(1(S) -ethoxycarbonyl-3-phenylpropyl)-L-alanine N-carboxy-anhydride under basic condition, carrying out decarboxylation under between neutral and acidic condition to obtain N-(1(S)-ethoxycarbonyl-3-phenylpropyl)-L-alanyl-amino acid, and forming a pharmacologically acceptable salt thereof, wherein the production of a by-product (3): is suppressed by carrying out in an aqueous liquid a series of operations till formation of the pharmacologically acceptable salt or till isolation of the pharmacologically acceptable salt. The present invention enables to prepare the pharmacologically acceptable salt of N-(1(S)-ethoxycarbonyl-3-phenylpropyl)-L-alanyl-amino acid having high quality, in a commercial scale with high yield and economical efficiency.
    • 提供了制备N-(1(S) - 乙氧基羰基-3-苯基丙基)-L-丙氨酰 - 氨基酸的药学上可接受的盐的方法,其包括将氨基酸和N-(1(S) - 乙氧基羰基 - 3-苯基丙基)-L-丙氨酸N-羧酸酐,在中性和酸性条件下进行脱羧,得到N-(1(S) - 乙氧基羰基-3-苯基丙基)-L-丙氨酰 - 氨基酸, 并形成其药学上可接受的盐,其中通过在含水液体中进行一系列操作直至形成药理学上可接受的盐或直到药理学上可接受的盐的分离来抑制副产物(3)的产生。 本发明能够以高产率和经济效益以商业规模制备质量高的N-(1(S) - 乙氧基羰基-3-苯基丙基)-L-丙氨酰 - 氨基酸的药理学上可接受的盐。
    • 4. 发明授权
    • Process for preparing pharmacologically acceptable salt of N-(1(S)-ethoxycarbonyl-3-phenylpropyl)-L-alanyl-amino acid
    • 制备N-(1(S) - 乙氧基羰基-3-苯基丙基)-L-丙氨酰 - 氨基酸的药理学上可接受的盐的方法
    • US06713628B2
    • 2004-03-30
    • US10295897
    • 2002-11-18
    • Yasuyoshi UedaKoichi KinoshitaTadashi MoroshimaYoshifumi YanagidaYoshihide Fuse
    • Yasuyoshi UedaKoichi KinoshitaTadashi MoroshimaYoshifumi YanagidaYoshihide Fuse
    • C07D20704
    • C07K5/0222C07K5/06026
    • There is provided a process for preparing a pharmacologically acceptable salt of N-(1(S)-ethoxycarbonyl-3-phenylpropyl)-L-alanyl-amino acid which comprises condensing an amino acid and N-(1(S)-ethoxycarbonyl-3-phenylpropyl)-L-alanine.N-carboxyanhydride under basic condition, carrying out decarboxylation under between neutral and acidic condition to obtain N-(1(S)-ethoxycarbonyl-3-phenylpropyl)-L-alanyl-amino acid, and forming a pharmacologically acceptable salt thereof, wherein the production of a by-product (3): is suppressed by carrying out in an aqueous liquid a series of operations till formation of the pharmacologically acceptable salt or till isolation of the pharmacologically acceptable salt. The present invention enables to prepare the pharmacologically acceptable salt of N-(1(S)-ethoxycarbonyl-3-phenylpropyl)-L-alanyl-amino acid having high quality, in a commercial scale with high yield and economical efficiency.
    • 提供了制备N-(1(S) - 乙氧基羰基-3-苯基丙基)-L-丙氨酰 - 氨基酸的药学上可接受的盐的方法,其包括将氨基酸和N-(1(S) - 乙氧基羰基 - 3-苯基丙基)-L-丙氨酸N-羧酸酐,在中性和酸性条件下进行脱羧,得到N-(1(S) - 乙氧基羰基-3-苯基丙基)-L-丙氨酰 - 氨基酸,和 形成其药理学上可接受的盐,其中通过在含水液体中进行一系列操作直到形成药理学上可接受的盐或直到药理学上可接受的盐的分离来抑制副产物(3)的产生。 本发明能够以高产率和经济效益以商业规模制备质量高的N-(1(S) - 乙氧基羰基-3-苯基丙基)-L-丙氨酰 - 氨基酸的药理学上可接受的盐。
    • 6. 发明授权
    • Process for producing N2-(1(S)-carboxy-3-phenylpropyl)-L-lysyl-L-proline
    • 制备N2-(1(S) - 羧基-3-苯基丙基)-L-赖氨酰-L-脯氨酸的方法
    • US06271393B1
    • 2001-08-07
    • US09554827
    • 2000-07-17
    • Tadashi MoroshimaYoshifumi YanagidaYoshihide FuseYasuyoshi Ueda
    • Tadashi MoroshimaYoshifumi YanagidaYoshihide FuseYasuyoshi Ueda
    • C07D20706
    • C07K5/0222
    • The process for producing N2-(1(S)-carboxy-3-phenylpropyl)-L-lysyl-L-proline in a simple, efficient and industrially advantageous manner, including the following steps: 1) subjecting N2-(1(S)-alkoxycarbonyl-3-phenylpropyl)-N6-trifluoroacetyl-L-lysyl-L-proline (1) to alkali hydrolysis in a mixed solution composed of water and a hydrophilic organic solvent using an inorganic base in an amount of n molar equivalents (n ≧ 3) per mole of the above compound (1), 2) neutralizing the hydrolysis product using an inorganic acid in an amount of (n − 1) to n molar equivalents (n ≧ 3) to form a compound (2) and removing the inorganic salt formed by causing the same to precipitate out from a solvent system suited for decreasing the solubility of the inorganic salt, and 3) causing the compound (2) existing in the mixture after removal of the inorganic salt to crystallize out at the isoelectric point thereof and thereby recovering the compound (2) in the form of crystals while retaining the salts including the trifluoroacetic acid-derived organic acid salt in a state dissolved in the mother liquor.
    • 包括以下步骤制备N2-(1(S) - 羧基-3-苯基丙基)-L-赖氨酰-L-脯氨酸的方法,包括以下步骤:1)使N2-(1(S ) - 烷氧基羰基-3-苯基丙基)-N6-三氟乙酰基-L-赖氨酰-L-脯氨酸(1)在由水和亲水性有机溶剂组成的混合溶液中使用n摩尔当量的无机碱进行碱水解( n)= 3),2)使用(n-1)〜n摩尔当量(n> = 3)的无机酸中和水解产物,形成化合物(2) ),并且通过使其从适合于降低无机盐的溶解度的溶剂体系中析出而形成的无机盐,以及3)除去无机盐以使其结晶出来,使存在于混合物中的化合物(2)结晶出来 其等电点,从而以晶体的形式回收化合物(2),同时保留盐 将三氟乙酸衍生的有机酸盐以溶解在母液中的状态。